胶原交联加强巩膜组织的研究进展  

Advanced research on collagen cross-linking for reinforcing the sclera

作　　者：张淼[1] 张丰菊[1] 

机构地区：[1]首都医科大学附属北京同仁医院北京同仁眼科中心北京市眼科学与视觉科学重点实验室,100730

出　　处：《中华眼视光学与视觉科学杂志》2015年第8期510-512,共3页Chinese Journal Of Optometry Ophthalmology And Visual Science

基　　金：北京市教委科技计划重点项目（Kz201310025027）;国家自然科学基金项目（81271041）

摘　　要：胶原交联技术在眼科的应用已经得到不断发展。其能够显著加强胶原纤维的机械强度的作用已被充分肯定，巩膜胶原交联可阻止进展性近视的发展，已成为眼科医生的关注热点。现总结蓝光核黄素交联与传统的紫外线核黄素交联方法的优缺点，并提出了蓝光核黄素交联方法可能取代紫外线核黄素交联方法成为治疗进展性近视的趋势。The use of collagen cross-linking is being developed continually due to its significance in the improvement of the mechanical strength of collagen fibers and its role in stopping myopia progression. This article discusses the advantages and disadvantages of traditional scleral UVA riboflavin cross-linking and blue-light riboflavin scleral cross-linking, The trend toward blue-light scleral cross-linking in replacing UVA cross-linking to prevent the progression of myopia is described in this review article.

关 键 词：胶原 交联 核黄素 蓝光 巩膜 

分 类 号：R77[医药卫生—眼科]